DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,525,906 | -0.6% | 10,181 | -3.8% | 0.14% | +2.9% |
| Q2 2023 | $2,540,160 | -1.1% | 10,584 | +3.8% | 0.14% | -14.5% |
| Q1 2023 | $2,569,548 | -87.4% | 10,195 | -86.7% | 0.16% | -88.0% |
| Q4 2022 | $20,382,929 | +4.9% | 76,795 | +2.1% | 1.32% | -5.4% |
| Q3 2022 | $19,435,000 | -1.2% | 75,246 | -3.1% | 1.40% | +11.8% |
| Q2 2022 | $19,679,000 | -20.4% | 77,622 | -7.9% | 1.25% | +20.4% |
| Q1 2022 | $24,732,000 | -19.2% | 84,314 | -9.4% | 1.04% | +3.7% |
| Q4 2021 | $30,607,000 | +663.6% | 93,028 | +606.7% | 1.00% | +641.5% |
| Q3 2021 | $4,008,000 | +15.8% | 13,164 | +2.0% | 0.14% | +16.4% |
| Q2 2021 | $3,460,000 | +20.6% | 12,902 | +1.2% | 0.12% | +5.5% |
| Q1 2021 | $2,870,000 | -9.1% | 12,750 | -10.3% | 0.11% | -20.3% |
| Q4 2020 | $3,157,000 | +2.1% | 14,211 | -1.0% | 0.14% | -13.2% |
| Q3 2020 | $3,092,000 | -2.5% | 14,358 | -19.9% | 0.16% | -9.7% |
| Q2 2020 | $3,170,000 | +63.4% | 17,926 | +27.9% | 0.18% | +20.5% |
| Q1 2020 | $1,940,000 | -29.9% | 14,018 | -22.2% | 0.15% | +21.7% |
| Q4 2019 | $2,766,000 | +17.1% | 18,022 | +10.2% | 0.12% | +0.8% |
| Q3 2019 | $2,362,000 | -10.3% | 16,356 | -11.2% | 0.12% | -4.8% |
| Q2 2019 | $2,632,000 | -11.9% | 18,413 | -18.6% | 0.12% | -13.2% |
| Q1 2019 | $2,987,000 | +41.6% | 22,622 | +10.6% | 0.14% | +10.8% |
| Q4 2018 | $2,109,000 | -20.1% | 20,454 | -15.8% | 0.13% | +30.0% |
| Q3 2018 | $2,641,000 | +51.6% | 24,305 | +37.7% | 0.10% | +42.9% |
| Q2 2018 | $1,742,000 | -7.6% | 17,653 | -8.3% | 0.07% | -6.7% |
| Q1 2018 | $1,885,000 | -1.7% | 19,250 | -6.9% | 0.08% | +1.4% |
| Q4 2017 | $1,918,000 | -21.7% | 20,667 | -27.6% | 0.07% | -27.5% |
| Q3 2017 | $2,449,000 | +10.4% | 28,555 | +8.6% | 0.10% | +2.0% |
| Q2 2017 | $2,218,000 | +4.6% | 26,286 | +6.0% | 0.10% | +5.3% |
| Q1 2017 | $2,121,000 | +22.4% | 24,796 | +11.4% | 0.10% | +18.8% |
| Q4 2016 | $1,733,000 | -7.7% | 22,258 | -7.1% | 0.08% | -10.1% |
| Q3 2016 | $1,878,000 | +6.1% | 23,958 | +36.7% | 0.09% | +3.5% |
| Q2 2016 | $1,770,000 | +48.1% | 17,521 | +39.1% | 0.09% | +38.7% |
| Q1 2016 | $1,195,000 | -7.4% | 12,594 | -9.4% | 0.06% | +1.6% |
| Q4 2015 | $1,291,000 | +48.2% | 13,896 | +35.9% | 0.06% | +22.0% |
| Q3 2015 | $871,000 | -27.8% | 10,222 | -27.5% | 0.05% | 0.0% |
| Q2 2015 | $1,206,000 | -42.5% | 14,092 | -43.0% | 0.05% | -39.0% |
| Q1 2015 | $2,097,000 | +15.5% | 24,703 | +16.6% | 0.08% | +10.8% |
| Q4 2014 | $1,816,000 | +32.3% | 21,188 | +17.2% | 0.07% | +15.6% |
| Q3 2014 | $1,373,000 | +4.3% | 18,071 | +8.1% | 0.06% | +10.3% |
| Q2 2014 | $1,317,000 | +7.2% | 16,723 | +2.1% | 0.06% | +3.6% |
| Q1 2014 | $1,229,000 | -31.6% | 16,383 | -29.6% | 0.06% | -30.0% |
| Q4 2013 | $1,796,000 | +44.6% | 23,265 | +29.8% | 0.08% | +21.2% |
| Q3 2013 | $1,242,000 | +26.5% | 17,921 | +15.5% | 0.07% | -4.3% |
| Q2 2013 | $982,000 | – | 15,520 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |